国药一致：公司会关注平衡应收账款和销售收入

Core Viewpoint - The company, China National Pharmaceutical Group Corporation (Sinopharm), reported that its business remains relatively stable, but it anticipates a highly competitive market landscape in the short term [1] Group 1: Business Performance - The company emphasized the importance of balancing accounts receivable and sales revenue while focusing on quality assurance [1] - Future profitability is expected to gradually improve as the company navigates the competitive environment [1]